1-3 of 3
Nobuo Masauzi
Close
Sort by
Journal Articles

Reduced-Intensity Versus Myeloablative Conditioning Allogeneic Hematopoietic Stem Cell Transplantation for Patients Aged Over 45 Years with Acute Lymphoblastic Leukemia (ALL) in Remission: A Study From the ALL Working Group of the Japan Society for Hematopoietic Cell Transplantation (JSHCT).

Junji Tanaka, MD, PhD, Kanamori Heiwa, MD, Nishiwaki Satoshi, MD, PhD, Ohashi Kazuteru, MD, Taniguchi Shuichi, MD, Eto Tetsuya, MD, Nakamae Hirohisa, MD, PhD, Yoshio Katayama, MD, PhD, Yasuo Morishima, MD, Ritsuro Suzuki, MD, PhD, Koji Kato, MD, Hisashi Sakamaki, MD, Nishimoto Naoki, MD, Nobuo Masauzi, MD
Journal: Blood
Blood (2012) 120 (21): 3027.
https://doi.org/10.1182/blood.V120.21.3027.3027
Published: 2012
Journal Articles

CD56 Expression Is the Potent Prognostic Marker of the Thalidomide Efficacy in the Patients with Multiple Myeloma.

Akio Mori, MD, PhD, Yutaka Tsutsumi, MD, PhD, Satoshi Hashino, MD, PhD, Hiroe Kanamori, MD, Makoto Ibata, MD, Shinobu Mashiko, MD, Nobuo Masauzi, MD, PhD, Masahiro Asaka, MD, PhD, Masahiro Imamura, MD, PhD
Journal: Blood
Blood (2005) 106 (11): 5142.
https://doi.org/10.1182/blood.V106.11.5142.5142
Published: 2005
Journal Articles

Effect of Granulocytes Colony Stimulating Factor on Decreased IL-12 p40 Production by Chemotherapy.

Tomomi Toubai, Junji Tanaka, Shuichi Ota, Takashi Fukuhara, Satoshi Hashino, Takeshi Kondo, Masanobu Morioka, Tsugumichi Kawamura, Nobuo Masauzi, Yasutaka Kakinoki, Hajime Kobayashi, Yasuyuki Kunieda, Masaharu Kasai, Mitsutoshi Kurosawa, Masahiro Imamura
Journal: Blood
Blood (2004) 104 (11): 4550.
https://doi.org/10.1182/blood.V104.11.4550.4550
Published: 2004